Selling pressure giving rise to some odd valuation outcomes.
Performance rights now under water; issued at tranche grant date issue price amounts between $2.68 to $3.33.
Institutional placement at 30 July 2020 raised $80m at a price of $3.05. Another $31m raised under share purchase plan at $3.05.
2020 revenue was $194m, 2021 was $258m, forecasts for 2022 circa $350m-$370m.
Add to My Watchlist
What is My Watchlist?
